Current report filing

Document and Entity Information

v3.22.2.2
Document and Entity Information
Oct. 28, 2022
Document And Entity Information [Line Items]  
Entity Registrant Name SeaStar Medical Holding Corp
Entity Address, State or Province CO
Amendment Flag true
Entity Central Index Key 0001831868
Document Type 8-K/A
Document Period End Date Oct. 28, 2022
Entity Incorporation State Country Code DE
Entity File Number 001-39927
Entity Tax Identification Number 85-3681132
Entity Address, Address Line One 3513 Brighton Blvd
Entity Address, Address Line Two Suite 410
Entity Address, City or Town Denver
Entity Address, Postal Zip Code 80216
City Area Code (844)
Local Phone Number 427-8100
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Description This Amendment No. 1 on Form 8-K/A (this “Amendment No. 1”) amends the Current Report on Form 8-K filed by SeaStar Medical Holding Corporation (f/k/a LMF Acquisition Opportunities, Inc. and the “Company”) on November 4, 2022 (the “Original Report”), in which the Company reported, among other events, the completion of the Business Combination. This Amendment No. 1 is filed to (1) update the Item 2.01 information to reflect Management’s Discussion and Analysis of Financial Condition and Results of Operations of SeaStar Medical for the three and nine months ended September 30, 2022 and September 30, 2021; and (2) amend the historical financial statements provided under Items 9.01(a) in the Original Report to include the unaudited interim financial statements of SeaStar Medical as of September 30, 2022 and for the three and nine months ended September 30, 2022 and September 30, 2021. This Amendment No. 1 does not amend any other item of the Original Report or purport to provide an update or a discussion of any developments at the Company subsequent to the filing date of the Original Report.
Common Stock [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol ICU
Security Exchange Name NASDAQ
Warrant [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share
Trading Symbol ICUCW
Security Exchange Name NASDAQ